Other IFN-related conditions, such as STING-associated vasculopathy with onset in infancy (SAVI) and tauopathies, including Alzheimer’s disease, both linked to dysregulated Type I IFN responses, warranting further research of C5aR2 in these contexts [38,39]. This evidence concerns the gene IFNA1 and tauopathy.